Search Results - david+irwin

1 Results

Sort By:

Novel Method for Applying Vasoactive Substances

Dr. David Irwin of The University of Colorado and Dr Thies Schroeder look to overcome barriers to drug delivery in patients with pulmonary arterial hypertension with the development of their novel method for applying an endothelin blocking compound (Ambrisentan) in a reverse nanoshell emulsifier to the lungs via a nebulized mist. Oral and injectable...

Published: 5/30/2023 | Inventor(s): David Irwin, Thies Schroeder, Mark Borden, David Pak, Justin Hopkins

Disease Areas Cardiology

Category(s): Therapeutics